Abstract
Recent reports have suggested that the total number of autologous or allogeneic hematopoietic stem cell (HSC) infused after high-dose chemotherapy might predict survival, post-transplant morbidity and rate of hematopoietic engraftment. However, HSC capable of long-term multilineage potential are still poorly defined, and tools for accurate and reproducible HSC enumeration are highly warranted.
MeSH terms
-
ADP-ribosyl Cyclase
-
ADP-ribosyl Cyclase 1
-
Antigens, CD*
-
Antigens, CD34 / analysis
-
Antigens, Differentiation / analysis
-
Blood Cell Count
-
Bone Marrow Cells / chemistry
-
Bone Marrow Cells / cytology*
-
Cell Separation
-
Fetal Blood / chemistry
-
Fetal Blood / cytology*
-
Flow Cytometry
-
Hematopoietic Stem Cell Transplantation
-
Hematopoietic Stem Cells / chemistry
-
Hematopoietic Stem Cells / cytology*
-
Humans
-
Membrane Glycoproteins
-
NAD+ Nucleosidase / analysis
-
Prognosis
Substances
-
Antigens, CD
-
Antigens, CD34
-
Antigens, Differentiation
-
Membrane Glycoproteins
-
ADP-ribosyl Cyclase
-
CD38 protein, human
-
NAD+ Nucleosidase
-
ADP-ribosyl Cyclase 1